Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant tumor with great variation in prognosis among individuals. Changes in metabolism influence disease progression and clinical outcomes. The objective of this study was to determine the overall survival (OS) risk of HCC patients from a metabolic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Hepatocell Carcinoma
Asıl Yazarlar: Weng, Jialei, Zhou, Chenhao, Zhou, Qiang, Chen, Wanyong, Yin, Yirui, Atyah, Manar, Dong, Qiongzhu, Shi, Yi, Ren, Ning
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2021
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018394/
https://ncbi.nlm.nih.gov/pubmed/33824863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S300633
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller